PELO
Gene Information
- Official Symbol: PELO
- Official Name: pelota mRNA surveillance and ribosome rescue factor
- Aliases and Previous Symbols: N/A
- Entrez ID: 53918
- UniProt: Q9BRX2
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Required for normal chromosome segregation during cell division and genomic stability (By similarity). May function in recognizing stalled ribosomes and triggering endonucleolytic cleavage of the mRNA, a mechanism to release non-functional ribosomes and degrade damaged mRNAs. May have ribonuclease activity (Potential). {ECO:0000250, ECO:0000305}.
Pfam Domains GO Terms
Pfam Domains
| eRF1 1 |
| eRF1 2 |
| eRF1 3 |
GO Terms
| nonfunctional rRNA decay |
| nuclear-transcribed mRNA catabolic process, non-stop decay |
| nuclear-transcribed mRNA catabolic process, no-go decay |
| ribosome disassembly |
| inner cell mass cell proliferation |
| ribonucleoprotein complex disassembly |
| mesenchymal to epithelial transition |
| RNA surveillance |
| blastocyst growth |
| rRNA catabolic process |
| ncRNA catabolic process |
| positive regulation of BMP signaling pathway |
| endonuclease activity |
| ribosome binding |
| organelle disassembly |
| endoderm development |
| regulation of BMP signaling pathway |
| blastocyst development |
| positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| stem cell population maintenance |
| maintenance of cell number |
| nuclear-transcribed mRNA catabolic process |
| mRNA catabolic process |
| rRNA metabolic process |
| regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| protein-containing complex disassembly |
| ribonucleoprotein complex subunit organization |
| RNA catabolic process |
| regulation of cellular response to growth factor stimulus |
| nucleic acid phosphodiester bond hydrolysis |
| nucleobase-containing compound catabolic process |
| in utero embryonic development |
| developmental growth |
| growth |
| cellular component disassembly |
| heterocycle catabolic process |
| cellular nitrogen compound catabolic process |
| aromatic compound catabolic process |
| ncRNA metabolic process |
| organic cyclic compound catabolic process |
| cell division |
| cell population proliferation |
| chordate embryonic development |
| embryo development ending in birth or egg hatching |
| epithelial cell differentiation |
| mRNA metabolic process |
| cellular macromolecule catabolic process |
| embryo development |
| macromolecule catabolic process |
| chromosome organization |
| epithelium development |
| cell cycle |
| positive regulation of signal transduction |
| RNA metabolic process |
| negative regulation of gene expression |
| tissue development |
| organic substance catabolic process |
| cellular catabolic process |
| positive regulation of cell communication |
| positive regulation of signaling |
| protein-containing complex subunit organization |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| HARS | 0.652 |
| MED16 | 0.643 |
| RPTOR | 0.64 |
| THG1L | 0.634 |
| ALG1 | 0.62 |
| PMM2 | 0.607 |
| GMPPB | 0.604 |
| RNMT | 0.597 |
| TRIAP1 | 0.582 |
| DPAGT1 | 0.58 |
| AARS | 0.58 |
| BUB3 | 0.579 |
| TSEN54 | 0.571 |
| CCDC101 | 0.569 |
| EIF4E | 0.565 |
| MTOR | 0.564 |
| RTCB | 0.561 |
| GFPT1 | 0.557 |
| PAM16 | 0.556 |
| UTP23 | 0.555 |
| UAP1 | 0.547 |
| ALG2 | 0.545 |
| TTI2 | 0.544 |
| DOHH | 0.544 |
| DHPS | 0.534 |
| RBM14 | 0.532 |
| ATXN10 | 0.531 |
| MEAF6 | 0.53 |
| EXOC3 | 0.53 |
| GTF3C4 | 0.529 |
| YARS | 0.528 |
| ORAOV1 | 0.526 |
| FNTA | 0.521 |
| TMEM41B | 0.52 |
| DAD1 | 0.519 |
| UHRF1 | 0.517 |
| WDR24 | 0.517 |
| WDR59 | 0.516 |
| TSEN34 | 0.505 |
| TGS1 | 0.504 |
| VEZT | 0.503 |
| NAE1 | 0.501 |
| DDX20 | 0.5 |
| TRMT5 | 0.5 |
| EPRS | 0.5 |
| MLLT1 | 0.499 |
| SRP14 | 0.499 |
| ADSL | 0.499 |
| HSPD1 | 0.498 |
| GNB1L | 0.498 |
| PPP2R3C | 0.496 |
| ALG13 | 0.49 |
| VHL | 0.49 |
| MED23 | 0.49 |
| TLE4 | 0.488 |
| DDOST | 0.487 |
| RPP21 | 0.484 |
| GTF3C3 | 0.481 |
| TTI1 | 0.481 |
| ENY2 | 0.479 |
| NARS | 0.478 |
| MAD2L1 | 0.478 |
| GTF3C2 | 0.476 |
| THOC6 | 0.475 |
| HCCS | 0.473 |
| ALG14 | 0.473 |
| DPF2 | 0.473 |
| CBFB | 0.472 |
| SPCS2 | 0.471 |
| MARS | 0.467 |
| PLAA | 0.466 |
| TEN1 | 0.464 |
| DR1 | 0.463 |
| TRNT1 | 0.463 |
| TBCA | 0.461 |
| LSM11 | 0.458 |
| SLC25A19 | 0.458 |
| GEMIN5 | 0.457 |
| POLR3H | 0.457 |
| TAMM41 | 0.456 |
| MED4 | 0.454 |
| SRP72 | 0.453 |
| SEH1L | 0.453 |
| GTF3C6 | 0.451 |
| PHB | 0.45 |
| SPCS3 | 0.45 |
| PDAP1 | 0.45 |
| RPE | 0.45 |
| ALG5 | 0.448 |
| SDHA | 0.448 |
| GEMIN8 | 0.446 |
| KNTC1 | 0.446 |
| TXNRD1 | 0.445 |
| NHLRC2 | 0.444 |
| WDR82 | 0.443 |
| VMP1 | 0.443 |
| RPN1 | 0.442 |
| EXOC4 | 0.442 |
| HAUS8 | 0.44 |
| TMED10 | 0.439 |
| CCT7 | 0.438 |
| GTF2A2 | 0.438 |
| DDX39A | 0.437 |
| BAP1 | 0.435 |
| OIP5 | 0.435 |
| OSGEP | 0.433 |
| MAD1L1 | 0.432 |
| ZNF259 | 0.431 |
| FAF2 | 0.428 |
| DICER1 | 0.427 |
| ABCF1 | 0.424 |
| CARS | 0.424 |
| DHDDS | 0.423 |
| ATP5J | 0.423 |
| SLC35B1 | 0.422 |
| EIF3F | 0.421 |
| ATP5O | 0.42 |
| LSMD1 | 0.419 |
| POLR3B | 0.419 |
| KCTD5 | 0.418 |
| NSMCE1 | 0.418 |
| LSM10 | 0.418 |
| GTF3A | 0.418 |
| PPCS | 0.417 |
| PPP4C | 0.417 |
| TELO2 | 0.416 |
| ROMO1 | 0.415 |
| APAF1 | 0.414 |
| MAX | 0.414 |
| GEMIN6 | 0.414 |
| ACTR10 | 0.413 |
| CRCP | 0.413 |
| LAMTOR5 | 0.412 |
| CEP350 | 0.412 |
| PYROXD1 | 0.411 |
| EEF1E1 | 0.411 |
| UBE2G2 | 0.41 |
| PPP6C | 0.409 |
| CASP9 | 0.409 |
| TAZ | 0.409 |
| ATP5H | 0.407 |
| CHCHD4 | 0.407 |
| DOLK | 0.406 |
| DDX1 | 0.406 |
| SEC62 | 0.406 |
| CSNK2B | 0.405 |
| MAPK14 | 0.405 |
| BUB1B | 0.405 |
| DCTN6 | 0.405 |
| CTDNEP1 | 0.403 |
| GABPA | 0.402 |
| PIK3R4 | 0.402 |
| PGGT1B | 0.401 |
| LMO2 | 0.401 |
| UBA3 | 0.401 |
| PISD | 0.401 |
| NUP50 | 0.4 |
| RAD1 | 0.4 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 436/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 17/28 |
| blood | 13/28 |
| bone | 19/26 |
| breast | 14/33 |
| central nervous system | 25/56 |
| cervix | 3/4 |
| colorectal | 8/17 |
| esophagus | 10/13 |
| fibroblast | 0/1 |
| gastric | 11/16 |
| kidney | 10/21 |
| liver | 10/20 |
| lung | 56/75 |
| lymphocyte | 11/16 |
| ovary | 12/26 |
| pancreas | 13/24 |
| peripheral nervous system | 8/16 |
| plasma cell | 5/15 |
| prostate | 0/1 |
| skin | 13/24 |
| soft tissue | 4/9 |
| thyroid | 2/2 |
| upper aerodigestive | 20/22 |
| urinary tract | 20/29 |
| uterus | 2/5 |
Essentiality in NALM6
- Essentiality Rank: 139
- Expression level (log2 read counts): 3.5
Expression Distribution
PELO Expression in NALM6 Cells: 3.5